DRUG · Unmapped registry intervention
Dexamethasone plus Radium-223
Find medicine records ·
Find other trials using this name
Clinical trial
Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC
NCT03432949
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedRadium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
University Health Network, Torontolead sponsor
Bayercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03432949 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.